Pfizer, Moderna and AstraZeneca Release COVID-19 Vaccine Trial Blueprints
Three vaccine makers, Pfizer Inc. (New York, NY, USA), AstraZeneca Cambridgeshire, England) and Moderna, Inc. (Cambridge, MA, USA), have released comprehensive road maps of their methods of evaluating their COVID-19 vaccines which are currently in trials. More...21 Sep 2020
Key Biomarkers Could Identify Patients at Risk for Severe Reaction to COVID-19 Infection
Researchers have identified key markers that could help pinpoint patients who are bound to get a severe reaction to COVID-19 infection. This would help doctors provide the right treatments at the right time, potentially saving lives. More...18 Sep 2020
Stroke Scans Could Reveal COVID-19 Infection
New research has found that COVID-19 may be diagnosed on the same emergency scans intended to diagnose stroke. The findings have important implications in the management of patients presenting with suspected stroke through early identification of COVID-19. More...18 Sep 2020
Study Finds T Cells Lead in Controlling SARS-CoV-2, Suggesting COVID-19 Vaccines Must Elicit Broad Immune Response
A new study has found that T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity, suggesting that vaccine candidates should aim to elicit a broad immune response that include antibodies, helper and killer T cells to ensure protective immunity. More...18 Sep 2020
New Insight into Structural Mechanism of Coronavirus Receptor Binding to Aid Development of COVID-19 Treatments and Vaccines
New insight into the mechanism of infection of the SARS-CoV-2 coronavirus could equip research groups with the understanding needed to inform studies into COVID-19 vaccines and treatments. More...18 Sep 2020
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Ultrasonic Cleaner
Cole-Parmer Ultrasonic Cleaner with Digital Timer
New
Cannulating Sphincterotome
TRUEtome
In Other News
New Generation of Long-Acting Immunotherapeutic Antivirals Aim to Prevent COVID-19/Flu ‘Twindemics’
FDA Publishes Comparative Performance Data for COVID-19 Molecular Diagnostic Tests
Researchers Find Possible Pathway to New Antiviral Drugs to Fight All Three Coronaviruses
Eli Lilly’s Neutralizing Antibody Therapy for COVID-19 Reduces Hospitalization Rates in Phase 2 Clinical Trial
Pfizer’s COVID-19 Vaccine Shows Mild-To-Moderate Side Effects in Phase 3 Clinical Trial
Self-Swab COVID-19 Collection Kit Receives FDA EUA for Use by CLIA-Certified Laboratories
First-in-Class Rapid Diagnostic Test Measures COVID-19 Neutralizing Antibodies in Plasma and Serum
Roche Granted FDA Emergency Use Authorization for Cobas SARS-CoV-2 & Influenza A/B Test
Scientists Developing Decoy Molecule as Therapeutic Against SARS-CoV-2 That Could Be Inhaled Directly Into the Lungs
Fujifilm Sonosite to Investigate Role of Point-of-Care Ultrasound in COVID-19 Patients Through Clinical Research
CT Scans of COVID-19 “Long-Haulers” Reveal Damaged Lungs Begin Repairing Themselves After 12 Weeks
COVID-19 Face Mask Containing Laser-Induced Graphene Deactivates Coronavirus Under Sunlight
COVID-19 Mathematical Model Indicates Flu Season May Cause 2.5-Fold Increase in Coronavirus Transmission
Scientists Retraining Coronavirus-Specific T Cells to Target Cancer Cells in Novel Immune-Oncology Approach
Scientists Use Cloud-Based Supercomputing and AI to Develop COVID-19 Treatments and Vaccine Models
Artificial Intelligence and Machine Learning Could Enhance Scientific Peer Review of COVID-19 Papers
Protective Immunity Against SARS-CoV-2 Short-Lived as Seasonal Coronavirus Can Reinfect People Every Year
World's First Commercially Available Saliva-Based COVID-19 Test Detects Coronavirus in 3-10 Minutes
Siemens Collaborates with CDC to Develop Process for Standardizing SARS-CoV-2 Assays
Oxford University to Evaluate Regeneron's Investigational Anti-Viral Antibody Cocktail in Hospitalized COVID-19 Patients
Universal Mask-Wearing Could Increase Population-Wide COVID-19 Immunity, Say Researchers
Stem Cells Offer Hope of Treatment for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS)
Merck Begins Human Trials of COVID-19 Vaccine Candidate; You Can’t Rush Science, Warns CEO
